TY - JOUR AU - Deza, Gustavo AU - Notario, Jaime AU - Ferran, Marta AU - Beltrán, Emma AU - Almirall, Miriam AU - Alcalá, Rebeca AU - Ruiz-Carrascosa, José Carlos AU - Sánchez, Ricardo AU - Pérez, Silvia AU - García-Vivar, María Luz AU - Galíndez, Eva AU - Mora, Maribel AU - Rodríguez, Jesús AU - Gallardo, Fernando PY - 2018 DO - 10.1007/s00296-018-4144-8 UR - http://hdl.handle.net/10668/12870 T2 - Rheumatology international AB - Although several randomized clinical trials and observational studies have evaluated the effectiveness, safety and drug survival of etanercept (ETN) in the treatment of psoriatic arthritis (PsA), long-term data regarding these aspects are currently... LA - en KW - Arthritis KW - Etanercept KW - Psoriasis KW - Psoriatic KW - Survival KW - TNF-α blockers KW - Adult KW - Aged KW - Aged, 80 and over KW - Antirheumatic Agents KW - Arthritis, Psoriatic KW - Drug Administration Schedule KW - Etanercept KW - Female KW - Humans KW - Male KW - Middle Aged KW - Practice Patterns, Physicians' KW - Retrospective Studies KW - Spain KW - Tertiary Care Centers KW - Time Factors KW - Treatment Outcome TI - Long-term etanercept survival in patients with psoriatic arthritis: a multicenter retrospective analysis in daily clinical practice in Spain. TY - research article VL - 38 ER -